Pfizer Covid vaccine trials data: have we been misled?

Pfizer Covid vaccine trials data: have we been misled?

An interesting peer reviewed article published this month by The British Medical Journal (BMJ) sheds a light on the shady modus operandi of Pfizer, one of the pharmaceutical companies in charge of Covid vaccines manufacturing and trials.

We certainly remember how fast these vaccines were produced and approved last year.

That speed “may have come at the cost of data integrity and patient safety”, according to The BMJ.

Poor laboratory management, patient safety concerns, and data integrity issues have been repeatedly reported by many labs employees in the US over the past year

A regional director who was employed at the research organisation Ventavia Research Group has told The BMJ that “the company falsified data, unblinded patients, employed inadequately trained vaccinators, and was slow to follow up on adverse events reported in Pfizer’s pivotal phase III trial”.


Helter skelter” work environment


“We have never experienced a “helter skelter” work environment as with Ventavia on Pfizer’s trial”, said another former Ventavia employee, speaking anonymously for fear of reprisal and loss of job prospects.

“It just seemed like something a little different from normal—the things that were allowed and expected.”

It is worth remembering that “Pfizer has hired Ventavia as a research subcontractor on four other vaccine clinical trials – Covid-19 vaccine in children and young adults, pregnant women, and a booster dose”, as reported by The BMJ

You can read the full article here.


Response to The BMJ investigation


After publishing the article, The BMJ wrote to Ventavia, Pfizer and the U.S. Food and Drug Administration (FDA) to “better clarify the scope and implications of the problems identified at Ventavia, as well as what corrective measures were taken”.

What was Ventavia answer to this? None, and more lies.

“To date, Ventavia has not responded to The BMJ’s repeated requests for information”, writes The British Medical Journal.

“However, in statements to other media outlets, Ventavia has claimed that its former employee did not work on Pfizer’s Covid-19 vaccine clinical trial. This claim is not true”, states The BMJ.

Dozens of documents, photos, audio recordings, and emails were reviewed by The BMJ’s editors, and the story externally peer reviewed before publication.

You can read the full article here.

Food for thought.